TBI
TrueBlue, Inc.
TBI lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
TBI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Weak |
TBI's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
TBI PE Valuation
TBI has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 18x next year's earnings.
TBI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect TBI to return to profit, with revenue growing.
TBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.69 | — |
| Q3 2026 | -$1.55 | -$0.59 |
| Q2 2026 | -$1.89 | -$0.73 |
| Q1 2026 | -$1.79 | +$2.81 |
| Q4 2025 | -$1.61 | +$2.56 |
| Q3 2025 | -$0.96 | +$2.88 |
| Q2 2025 | -$1.16 | +$2.42 |
| Q1 2025 | -$4.60 | -$4.23 |
| Q4 2024 | -$4.17 | -$3.72 |
TBI is still losing money, but far less than before: $1.55 per share over the past year, against $4.60 at its worst in early 2025.
TBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $520.7M | +21% |
| Q2 2026 | $443M | +12% |
| Q1 2026 | $398.6M | +7.6% |
| Q4 2025 | $418.2M | +8.3% |
| Q3 2025 | $431.3M | +13% |
| Q2 2025 | $396.3M | 0% |
| Q1 2025 | $370.3M | -8.1% |
| Q4 2024 | $386M | -22% |
TBI's revenue is recovering but still below its 2021 peak: $521M last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.3% | +2.3 points |
| Q2 2026 | -0.3% | +0.5 points |
| Q1 2026 | -4.5% | -0.7 points |
| Q4 2025 | -7% | -4.3 points |
| Q3 2025 | 0% | +1.8 points |
| Q2 2025 | -0.7% | +14 points |
| Q1 2025 | -3.8% | 0 points |
| Q4 2024 | -2.7% | -1 points |
TBI's operating margin was 2.3% last quarter, up 2.3 points from the same quarter a year ago.
TBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$28.3M | -$4.9M |
| Q2 2026 | -$24M | -$7.9M |
| Q1 2026 | -$12.6M | +$14.2M |
| Q4 2025 | -$7.5M | -978% |
| Q3 2025 | -$23.4M | -$10.7M |
| Q2 2025 | -$16.1M | -$8.3M |
| Q1 2025 | -$26.8M | -$5.2M |
| Q4 2024 | $854K | -88% |
TBI has burned cash in seven of the last eight quarters: −$72M over the past year, against −$65M the year before.
TBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +7.3% | +2.2M shares |
| 1 year | +9.2% | +2.7M shares |
| 3 years | +5.5% | +1.7M shares |
| 5 years | -8% | -2.8M shares |
| Available history | -17% | -6.5M shares |
TBI has 33M diluted shares, up 9.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $8,000 |
| Q3 2024 | $4.3M |
| Q2 2024 | $6.9M |
| Q1 2024 | $10.1M |
TBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 929.0x | High |
| Q4 2023 | -31.4x | Net Cash |
| Q3 2023 | -2.7x | Net Cash |
| Q2 2023 | -1.1x | Net Cash |
| Q1 2023 | -0.6x | Net Cash |
| Q4 2022 | -0.7x | Net Cash |
| Q3 2022 | -0.4x | Net Cash |
| Q2 2022 | -0.3x | Net Cash |
TBI's net debt is more than 20 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
TBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.8 | Overbought |
| Stochastic | 74.6 | Neutral |
TBI's weekly RSI is 71 (overbought) and its Stochastic is 75 (neutral).
TBI PE vs Industrials Sector
| Metric | TBI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
TBI has no meaningful PE right now: it lost money over the past year.
TBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.92 | 24% above |
| 20 week MA | $9.34 | 32% above |
| 50 week MA | $6.73 | 84% above |
| 100 week MA | $6.42 | 92% above |
| 200 week MA | $9.78 | 26% above |
TBI has climbed back above all five of its weekly moving averages, and it's now 26% above its 200-week average.
TBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.6 | $19.2 | -19% |
| 2021 | $19.2 | $27.7 | +44% |
| 2022 | $27.7 | $19.2 | -30% |
| 2023 | $19.2 | $15.3 | -20% |
| 2024 | $15.3 | $7.87 | -49% |
| 2025 | $7.87 | $4.65 | -41% |
| 2026 YTD | $4.65 | $12.4 | +166% |
TBI has finished four years in a row lower, and it's up 166% so far in 2026.